Synthetic Approaches and Pharmacological Activity of 1,3,4-Oxadiazoles: A Review of the Literature from 2000–2012

This review provides readers with an overview of the main synthetic methodologies for 1,3,4-oxadiazole derivatives, and of their broad spectrum of pharmacological activities as reported over the past twelve years.

[1]  C. Kazak,et al.  Design and One‐Pot and Microwave‐Assisted Synthesis of 2‐Amino/5‐Aryl‐1,3,4‐oxadiazoles Bearing a Benzimidazole Moiety as Antioxidants , 2012, Archiv der Pharmazie.

[2]  M. B. Kalashetti,et al.  Synthesis, hypoglycemic and hypolipidemic activities of novel thiazolidinedione derivatives containing thiazole/triazole/oxadiazole ring. , 2012, European journal of medicinal chemistry.

[3]  B. Poojary,et al.  Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents. , 2012, European journal of medicinal chemistry.

[4]  B. Ahmed,et al.  1,3,4-oxadiazole: a biologically active scaffold. , 2012, Mini reviews in medicinal chemistry.

[5]  Andrew G. Leach,et al.  Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes. , 2012, Bioorganic & medicinal chemistry letters.

[6]  J. Barbosa-Filho,et al.  Synthesis, Molecular Properties Prediction, and Anti-staphylococcal Activity of N-Acylhydrazones and New 1,3,4-Oxadiazole Derivatives , 2012, Molecules.

[7]  Daohang He,et al.  Synthesis and optical properties of novel anthracene-based stilbene derivatives containing an 1,3,4-oxadiazole unit , 2012 .

[8]  Y. Geng,et al.  Hydroxyl may not be indispensable for raltegravir: Design, synthesis and SAR Studies of raltegravir derivatives as HIV-1 inhibitors. , 2012, European journal of medicinal chemistry.

[9]  Kazuo Kitaura,et al.  Structure-based design of novel potent protein kinase CK2 (CK2) inhibitors with phenyl-azole scaffolds. , 2012, Journal of medicinal chemistry.

[10]  C. Kappe,et al.  High-temperature continuous flow synthesis of 1,3,4-oxadiazoles via N-acylation of 5-substituted tetrazoles , 2012 .

[11]  F. Badria,et al.  Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles. , 2012, European journal of medicinal chemistry.

[12]  Hui Yu,et al.  A Novel One‐Pot Synthesis of α‐Keto‐1,3,4‐oxadiazole Derivatives Based on Isocyanide‐Nef Reaction. , 2012 .

[13]  J. Serrano,et al.  Liquid Crystalline Ionic Dendrimers Containing Luminescent Oxadiazole Moieties , 2012 .

[14]  Jonas Boström,et al.  Oxadiazoles in medicinal chemistry. , 2012, Journal of medicinal chemistry.

[15]  J. Paquin,et al.  Synthesis of 1,3,4-oxadiazoles from 1,2-diacylhydrazines using [Et2NSF2]BF4 as a practical cyclodehydration agent. , 2012, Organic & biomolecular chemistry.

[16]  A. Kudelko,et al.  Microwave-assisted synthesis of 2-styryl-1,3,4-oxadiazoles from cinnamic acid hydrazide and triethyl orthoesters , 2012 .

[17]  S. Gattani,et al.  Identification and development of 2,5-disubstituted oxadiazole as potential candidate for treatment of XDR and MDR tuberculosis. , 2012, European journal of medicinal chemistry.

[18]  O. Ali,et al.  Synthesis and Antimicrobial Activity of New 2,5‐Disubstituted 1,3,4‐Oxadiazoles and 1,2,4‐Triazoles and Their Sugar Derivatives , 2012 .

[19]  Kai Liu,et al.  Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents. , 2012, European journal of medicinal chemistry.

[20]  P. Kumari,et al.  Synthesis of coumarin-based 1,3,4-oxadiazol-2ylthio-N-phenyl/benzothiazolyl acetamides as antimicrobial and antituberculosis agents , 2012, Medicinal Chemistry Research.

[21]  P. Kumari,et al.  Synthesis of novel 3-(5-sulfanyl-1,3,4-oxadiazol-2-yl)-2H-chromen-2-one condensed s-triazinyl piperazines and piperidines as antimicrobial agents , 2012, Medicinal Chemistry Research.

[22]  Bruce J. Melancon,et al.  The Discovery and Characterization of ML218: A Novel, Centrally Active T-Type Calcium Channel Inhibitor with Robust Effects in STN Neurons and in a Rodent Model of Parkinson's Disease. , 2011, ACS chemical neuroscience.

[23]  J. Kunitomo,et al.  A novel glycogen synthase kinase‐3 inhibitor 2‐methyl‐5‐(3‐{4‐[(S )‐methylsulfinyl]phenyl}‐1‐benzofuran‐5‐yl)‐1,3,4‐oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer’s disease , 2011, Journal of neurochemistry.

[24]  Yan-Bin Zhang,et al.  Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents. , 2011, Bioorganic & medicinal chemistry.

[25]  Jian Wang,et al.  Synthesis and Antifungal Activity of Novel Sulfone Derivatives Containing 1,3,4-Oxadiazole Moieties , 2011, Molecules.

[26]  P. Zhan,et al.  1,3,4-oxadiazole: a privileged structure in antiviral agents. , 2011, Mini reviews in medicinal chemistry.

[27]  Hui Yu,et al.  A novel one-pot synthesis of α-keto-1,3,4-oxadiazole derivatives based on isocyanide-Nef reaction , 2011 .

[28]  T. Ghosh,et al.  Cu(II) catalyzed imine C-H functionalization leading to synthesis of 2,5-substituted 1,3,4-oxadiazoles. , 2011, Organic letters.

[29]  R. Veerasamy,et al.  2,5-Disubstituted-1,3,4-oxadiazoles/thiadiazole as surface recognition moiety: design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors. , 2011, Bioorganic & medicinal chemistry letters.

[30]  A. Monkman,et al.  Bipolar molecules with high triplet energies: synthesis, photophysical, and structural properties. , 2011, The Journal of organic chemistry.

[31]  A. Ramazani,et al.  The reaction of (N‐isocyanimino) triphenylphosphorane with (E)‐3‐aryl‐2‐ propenoic acid derivatives: One‐pot synthesis of 2‐[(E)‐2‐aryl‐1‐ethenyl]‐1,3,4‐oxadiazoles via intramolecular aza‐Wittig reaction , 2011 .

[32]  Lingzhou Zhao,et al.  Molecular Modeling Studies on Benzimidazole Carboxamide Derivatives as PARP‐1 Inhibitors Using 3D‐QSAR and Docking , 2011, Chemical biology & drug design.

[33]  Rajnish Kumar,et al.  Synthesis, antibacterial evaluation and QSAR studies of 7-[4-(5-aryl-1,3,4-oxadiazole-2-yl)piperazinyl] quinolone derivatives. , 2011, European journal of medicinal chemistry.

[34]  Z. Kaplancıklı.  Synthesis of Some Oxadiazole Derivatives as New Anticandidal Agents , 2011, Molecules.

[35]  P. Mátyus,et al.  3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: a new scaffold for the selective inhibition of monoamine oxidase B. , 2011, Journal of medicinal chemistry.

[36]  A. Ramazani,et al.  One‐Pot, Four‐Component Synthesis of Fully Substituted 1,3,4‐Oxadiazole Derivatives from (Isocyanoimino)triphenylphosphorane, a Primary Amine, an Aromatic Carboxylic Acid, and Chloroacetone , 2011 .

[37]  A. Ramazani,et al.  One-Pot Efficient Synthesis of Fully Substituted 1,3,4-Oxadiazole Derivatives from (N-Isocyanimino)triphenylphosphorane, Carboxylic Acids, and Aromatic Bis-Aldehydes , 2011 .

[38]  B. Ma,et al.  Novel Cytochrome P450-Mediated Ring Opening of the 1,3,4-Oxadiazole in Setileuton, a 5-Lipoxygenase Inhibitor , 2011, Drug Metabolism and Disposition.

[39]  T. Farghaly,et al.  Synthesis of new functionalized 3-substituted [1,2,4]triazolo [4,3-a]pyrimidine derivatives: potential antihypertensive agents. , 2011, Acta poloniae pharmaceutica.

[40]  A. Dadras,et al.  Synthesis and herbicidal activity of novel 5-chloro-3-fluoro-2-phenoxypyridines with a 1,3,4-oxadiazole ring , 2011 .

[41]  A. Ramazani,et al.  The Reaction of (N‐Isocyanimino)triphenylphosphorane with Biacetyl in the Presence of Aromatic Carboxylic Acids: Efficient One‐Pot Three‐Component Reaction for the Synthesis of 3‐(5‐Aryl‐1,3,4‐oxadiazol‐2‐yl)‐3‐hydroxybutan‐2‐one Derivatives , 2011 .

[42]  B. Lotfi,et al.  Electrocyclization of Semicarbazone; A Novel Route of Green Synthesis of 2,5-Disubstituted-1,3,4-Oxadiazoles , 2011 .

[43]  S. Kiran.  1, 3, 4 OXADIAZOLE: A POTENT DRUG CANDIDATE WITH VARIOUS PHARMACOLOGICAL ACTIVITIES , 2011 .

[44]  S. Gaonkar,et al.  Microwave-Assisted Solution Phase Synthesis of Novel 2-{4-[2-(N-Methyl-2-pyridylamino)ethoxy]phenyl}-5-Substituted 1,3,4-Oxadiazole Library , 2011 .

[45]  A. Chabukswar,et al.  Microwave assisted one pot synthesis of some novel 2,5-disubstituted 1,3,4-oxadiazoles as antifungal agents. , 2011, Bioorganic & medicinal chemistry letters.

[46]  S. Kashaw,et al.  Synthesis, anticonvulsant and neurotoxic activity of some new 2,5-disubstituted-1,3,4-oxadiazoles , 2011, Medicinal Chemistry Research.

[47]  A. Ramazani,et al.  A novel four-component reaction for the synthesis of disubstituted 1,3,4-oxadiazole derivatives , 2011, Molecular Diversity.

[48]  M. Abdollahi,et al.  Synthesis and analgesic activity of new 1,3,4-oxadiazoles and 1,2,4-triazoles , 2011, Medicinal Chemistry Research.

[49]  Ravi S. Lamani,et al.  A convenient synthesis of 1,3,4-thiadiazole and 1,3,4-oxadiazole based peptidomimetics employing diacylhydrazines derived from amino acids , 2010 .

[50]  Abdul Samad,et al.  Molecular properties prediction, synthesis and antimicrobial activity of some newer oxadiazole derivatives. , 2010, European journal of medicinal chemistry.

[51]  M. Khanfar,et al.  Discovery of novel GSK-3β inhibitors with potent in vitro and in vivo activities and excellent brain permeability using combined ligand- and structure-based virtual screening. , 2010, Journal of medicinal chemistry.

[52]  J. Keshavayya,et al.  Synthesis and antimicrobial activity of 2-substituted [4-(1,3,4-oxadiazol-2-yl methyl)] phthalazin-1(2H)-one derivatives. , 2010, European journal of medicinal chemistry.

[53]  M. Yamada,et al.  Synthesis and evaluation of novel stearoyl-CoA desaturase 1 inhibitors: 1'-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-3,4-dihydrospiro[chromene-2,4'-piperidine] analogs. , 2010, European journal of medicinal chemistry.

[54]  P. L. Lobo,et al.  Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives. , 2010, European journal of medicinal chemistry.

[55]  A. Jadhav,et al.  Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1. , 2010, Journal of medicinal chemistry.

[56]  A. Malikzay,et al.  Antitumor Activity of IMC-038525, a Novel Oral Tubulin Polymerization Inhibitor. , 2010, Translational oncology.

[57]  B. Kalluraya,et al.  Synthesis and biological property of some novel 1,3,4-oxadiazoles. , 2010, European journal of medicinal chemistry.

[58]  N. Siddiqui,et al.  Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives of isoniazid. , 2010, Bioorganic & medicinal chemistry letters.

[59]  P. Mishra,et al.  Novel semicarbazones based 2,5-disubstituted-1,3,4-oxadiazoles: one more step towards establishing four binding site pharmacophoric model hypothesis for anticonvulsant activity. , 2010, Bioorganic & medicinal chemistry letters.

[60]  Kenji Matsuno,et al.  Identification of a New Series of STAT3 Inhibitors by Virtual Screening. , 2010, ACS medicinal chemistry letters.

[61]  K. Bothara,et al.  Design, synthesis, and evaluation of anti-inflammatory, analgesic, ulcerogenicity, and nitric oxide releasing studies of novel indomethacin analogs as non-ulcerogenic derivatives , 2010, Journal of enzyme inhibition and medicinal chemistry.

[62]  Monica Sharma,et al.  Synthesis and antipsychotic and anticonvulsant activity of some new substituted oxa/thiadiazolylazetidinonyl/thiazolidinonylcarbazoles. , 2010, European journal of medicinal chemistry.

[63]  I. Davies,et al.  A practical synthesis of 5-lipoxygenase inhibitor MK-0633. , 2010, The Journal of organic chemistry.

[64]  A. Ramazani,et al.  Novel one-pot, four-component condensation reaction: an efficient approach for the synthesis of 2,5-disubstituted 1,3,4-oxadiazole derivatives by a Ugi-4CR/aza-Wittig sequence. , 2010, Organic letters.

[65]  V. Bobade,et al.  N-Chlorosuccinimide/1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU)–Mediated Synthesis of 2,5-Disubstituted 1,3,4-Oxadiazoles , 2010 .

[66]  R. Somani,et al.  Studies of CNS Activities of Some Mannich bases of 1,3,4-Oxadiazole , 2010 .

[67]  S. Lata,et al.  Synthesis of substituted acridinyl pyrazoline derivatives and their evaluation for anti-inflammatory activity. , 2010, European journal of medicinal chemistry.

[68]  G. V. Suresh Kumar,et al.  Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents. , 2010, European journal of medicinal chemistry.

[69]  J. Patel,et al.  Synthesis and Antimicrobial Activity of 3-(1,3,4-Oxadiazol-2-yl)quinazolin-4(3H)-ones , 2010, Scientia pharmaceutica.

[70]  Christine Brideau,et al.  The discovery of setileuton, a potent and selective 5-lipoxygenase inhibitor. , 2010, ACS medicinal chemistry letters.

[71]  P. Shetty,et al.  Synthesis, characterization and biological activity of some new 1,3,4-oxadiazole bearing 2-flouro-4-methoxy phenyl moiety. , 2010, European journal of medicinal chemistry.

[72]  S. Singh,et al.  Electrochemical synthesis of 5-substituted-2-amino (substituted amino)-1,3,4-oxadiazoles at the platinum electrode , 2010 .

[73]  P. G. Nayak,et al.  A possible correlation between the correction of endothelial dysfunction and normalization of high blood pressure levels by 1,3,4-oxadiazole derivative, an L-type Ca2+ channel blocker in deoxycorticosterone acetate and N(G)-nitro-l-arginine hypertensive rats. , 2010, Chemico-biological interactions.

[74]  M. Yamada,et al.  Novel spiropiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 1'-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4'-piperidine]. , 2010, Bioorganic & medicinal chemistry letters.

[75]  Ryan S. Davis,et al.  Design, synthesis, and biological evaluations of 2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoline analogs of combretastatin-A4. , 2010, Journal of medicinal chemistry.

[76]  N. Siddiqui,et al.  Synthesis, anticonvulsant and neurotoxicity of some novel 1,3,4-oxadiazole derivatives of phthalimide , 2010 .

[77]  A. Ramazani,et al.  The reaction of (N‐isocyanimino) triphenylphosphorane with an electron‐poor α‐haloketone in the presence of aromatic carboxylic acids: A novel three‐component reaction for the synthesis of disubstituted 1,3,4‐oxadiazole derivatives , 2010 .

[78]  J. Carvalho,et al.  Synthesis, antitumor and antimicrobial activity of novel 1-substituted phenyl-3-[3-alkylamino(methyl)-2-thioxo-1,3,4-oxadiazol-5-yl] β-carboline derivatives , 2010 .

[79]  S. Bala,et al.  Heterocyclic 1, 3, 4-oxadiazole compounds with diverse biological activities: A comprehensive review , 2010 .

[80]  Sanjeev Kumar.  ANODIC SYNTHESIS, SPECTRAL CHARACTERIZATION AND ANTIMICROBIAL ACTIVITY OF NOVEL 2-AMINO-5-SUBSTITUTED-1,3,4-OXADIAZOLES , 2010 .

[81]  I. H. Tomi,et al.  Synthesis, characterization and effect of bis-1,3,4- oxadiazole rings containing glycine moiety on the activity of some transferase enzymes , 2010 .

[82]  P. Mishra,et al.  Anticonvulsant and sedative-hypnotic activity of some novel 3-[5-(4-substituted) phenyl-1,3,4-oxadiazole-2yl]-2-styrylquinazoline-4(3H)-ones , 2010, Medicinal Chemistry Research.

[83]  F. Attaby,et al.  Anti-Alzheimer and Anti-Cox-2 Activities of the Newly Synthesized 2,3′-Bipyridine Derivatives (I) , 2009 .

[84]  M. M. Elsayed,et al.  Anti-Alzheimer and Anti-COX-2 Activities of the Newly Synthesized 2,3′-Bipyridine Derivatives (II) , 2009 .

[85]  S. R. Shukla,et al.  Synthesis and antibacterial activity of some novel bis-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and bis-4-thiazolidinone derivatives from terephthalic dihydrazide. , 2009, European journal of medicinal chemistry.

[86]  Martin J. Stoermer,et al.  In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. , 2009, Antiviral research.

[87]  Changkun Li,et al.  A mild, one-pot preparation of 1,3,4-oxadiazoles , 2009 .

[88]  P. G. Nayak,et al.  Vasorelaxant effect in rat aortic rings through calcium channel blockage: a preliminary in vitro assessment of a 1,3,4-oxadiazole derivative. , 2009, Chemico-biological interactions.

[89]  O. Aly,et al.  Design, synthesis and hypolipidemic activity of novel 2-(naphthalen-2-yloxy)propionic acid derivatives as desmethyl fibrate analogs. , 2009, European journal of medicinal chemistry.

[90]  B. Jayashankar,et al.  Synthesis and pharmacological evaluation of 1,3,4-oxadiazole bearing bis(heterocycle) derivatives as anti-inflammatory and analgesic agents. , 2009, European journal of medicinal chemistry.

[91]  J. Kunitomo,et al.  2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta with good brain permeability. , 2009, Journal of medicinal chemistry.

[92]  A. Husain,et al.  Fenbufen based 3-[5-(substituted aryl)-1,3,4-oxadiazol-2-yl]-1-(biphenyl-4-yl)propan-1-ones as safer antiinflammatory and analgesic agents. , 2009, European journal of medicinal chemistry.

[93]  R. Vaickelionienė,et al.  Synthesis of substituted 1,3,4-oxadiazole derivatives , 2009 .

[94]  M. Akhter,et al.  Aroylpropionic acid based 2,5-disubstituted-1,3,4-oxadiazoles: synthesis and their anti-inflammatory and analgesic activities. , 2009, European journal of medicinal chemistry.

[95]  Vijender Singh,et al.  Synthesis and Antimicrobial Evaluation of Some New Oxadiazoles Derived from Phenylpropionohydrazides , 2009, Molecules.

[96]  I. Baciu,et al.  Convenient preparation of unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles promoted by Dess-Martin reagent , 2009 .

[97]  E. Garvey,et al.  1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position. , 2009, Bioorganic & medicinal chemistry letters.

[98]  J. Kunitomo,et al.  Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta. , 2009, Bioorganic & medicinal chemistry.

[99]  N. James,et al.  Zibotentan endothelin ETA receptor antagonist oncolytic , 2009 .

[100]  C. S. Rajput,et al.  Synthesis and anti-inflammatory activity of newer quinazolin-4-one derivatives. , 2009, European journal of medicinal chemistry.

[101]  H. Kumar,et al.  1,3,4-Oxadiazole/thiadiazole and 1,2,4-triazole derivatives of biphenyl-4-yloxy acetic acid: synthesis and preliminary evaluation of biological properties. , 2008, European journal of medicinal chemistry.

[102]  T. V. Artamonova,et al.  Tetrazoles: LIII. Microwave-activated acylation of 5-substituted tetrazoles , 2008 .

[103]  D. Pore,et al.  Trichloroisocyanuric Acid–Mediated One-Pot Synthesis of Unsymmetrical 2,5-Disubstituted 1,3,4-Oxadiazoles at Ambient Temperature , 2008 .

[104]  E. El‐Ashry,et al.  Synthesis and Antiviral Evaluation of Novel 5-(N-Arylaminomethyl-1,3,4-oxadiazol-2-yl)hydrazines and Their Sugars, 12,4-Triazoles, Tetrazoles and Pyrazolyl Derivatives. , 2008 .

[105]  D. Boger,et al.  Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase. , 2008, Journal of medicinal chemistry.

[106]  Mohamed Ashraf Ali,et al.  anti-HAV Activity of Some Newly Synthesized Triazolo[4,3-b]pyridazines. , 2008 .

[107]  Qiong Chen,et al.  Syntheses of Diheterocyclic Compounds Based on 2-Thioacetohydrazide-5,7-dimethyl-1,2,4-triazolo[1,5-a]-pyrimidine , 2008, Molecules.

[108]  R. Varma,et al.  Greener and Rapid Access to Bioactive Heterocycles: One-Pot Solvent-Free Synthesis of 1,3,4-Oxadiazoles and 1,3,4-Thiadiazoles. , 2008 .

[109]  C. Draghici,et al.  Synthesis and Biological Evaluation of Various New Substituted 1,3,4-oxadiazole-2-thiols , 2008 .

[110]  E. El‐Ashry,et al.  Synthesis and Antiviral Evaluation of Novel 5‐(N‐Aryl‐aminomethyl‐1,3,4‐oxadiazol‐2‐yl)hydrazines and Their Sugars, 1,2,4‐Triazoles, Tetrazoles and Pyrazolyl Derivatives , 2008, Archiv der Pharmazie.

[111]  Z. Temesgen,et al.  Raltegravir: first in class HIV integrase inhibitor , 2008, Therapeutics and clinical risk management.

[112]  R. Varma,et al.  Greener and rapid access to bio-active heterocycles: one-pot solvent-free synthesis of 1,3,4-oxadiazoles and 1,3,4-thiadiazoles , 2008 .

[113]  Zheng Li,et al.  Silica-Supported Dichlorophosphate: a Recoverable Cyclodehydrant for the Eco-Friendly Synthesis of 2,5-Disubstituted 1,3,4-Oxadiazoles under Solvent-Free and Microwave Irradiation Conditions , 2008 .

[114]  P. Mishra,et al.  Synthesis and antimicrobial activity of some new 3–[5-(4-substituted) phenyl-1,3,4-oxadiazole-2yl]-2- styrylquinazoline-4(3H)-ones , 2008, Medicinal Chemistry Research.

[115]  Ilkay Küçükgüzel,et al.  Synthesis of some novel heterocyclic compounds derived from diflunisal hydrazide as potential anti-infective and anti-inflammatory agents. , 2007, European journal of medicinal chemistry.

[116]  Mohamed Ashraf Ali,et al.  Oxadiazole mannich bases: synthesis and antimycobacterial activity. , 2007, Bioorganic & medicinal chemistry letters.

[117]  A. Ramazani,et al.  The Reaction of (N‐Isocyanimino)triphenylphosphorane with Benzoic Acid Derivatives: A Novel Synthesis of 2‐Aryl‐1,3,4‐oxadiazole Derivatives. , 2007 .

[118]  Pamela J. Martin,et al.  Hydrogen‐bonded oxadiazole mesogens , 2007 .

[119]  M. Amir,et al.  Synthesis and evaluation of anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation properties of ibuprofen derivatives , 2007, Acta pharmaceutica.

[120]  M. Ali,et al.  Synthesis and Anti Tuberculostatic Activity of Novel 1,3,4‐Oxadiazole Derivatives , 2007 .

[121]  A. Kadi,et al.  Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazoles. , 2007, European journal of medicinal chemistry.

[122]  C. Supuran,et al.  Synthesis and antimalarial activity of novel chiral and achiral benzenesulfonamides bearing 1, 3, 4-oxadiazole moieties , 2007, Journal of enzyme inhibition and medicinal chemistry.

[123]  A. Shafiee,et al.  Synthesis, anticonvulsant and muscle relaxant activities of substituted 1,3,4-oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole , 2007 .

[124]  A. Savarino.  A historical sketch of the discovery and development of HIV-1 integrase inhibitors , 2006, Expert opinion on investigational drugs.

[125]  I. Davies,et al.  Superior reactivity of thiosemicarbazides in the synthesis of 2-amino-1,3,4-oxadiazoles. , 2006, The Journal of organic chemistry.

[126]  M. Dabiri,et al.  A facile procedure for the one-pot synthesis of unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles , 2006 .

[127]  D. Kelley,et al.  One pot direct synthesis of oxazolines, benzoxazoles, and oxadiazoles from carboxylic acids using the Deoxo-Fluor reagent , 2006 .

[128]  Thiam Hong Ang,et al.  Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agents. , 2006, Antiviral research.

[129]  Hemaka A. Rajapakse,et al.  A mild and efficient one pot synthesis of 1,3,4-oxadiazoles from carboxylic acids and acyl hydrazides , 2006 .

[130]  J. Balsells,et al.  Synthesis of 2-amino-5-substituted-1,3,4-oxadiazoles using 1,3-dibromo-5,5-dimethylhydantoin as oxidant , 2006 .

[131]  M. Shafique,et al.  Synthesis, Antimicrobial and Anti‐HIV Activity of Some Novel Benzenesulfonamides Bearing 2,5‐Disubstituted‐1,3,4‐Oxadiazole Moiety , 2006 .

[132]  J. Palmer,et al.  Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors. , 2006, Journal of medicinal chemistry.

[133]  A. Malikzay,et al.  Oxadiazole derivatives as a novel class of antimitotic agents: Synthesis, inhibition of tubulin polymerization, and activity in tumor cell lines. , 2006, Bioorganic & medicinal chemistry letters.

[134]  M. Shi,et al.  Halogen effects in Robinson–Gabriel type reaction of cyclopropanecarboxylic acid N′-substituted-hydrazides with PPh3/CX4 , 2005 .

[135]  Mahmud Tareq Hassan Khan,et al.  Structure-activity relationships of tyrosinase inhibitory combinatorial library of 2,5-disubstituted-1,3,4-oxadiazole analogues. , 2005, Bioorganic & medicinal chemistry.

[136]  A. Malin,et al.  ORGANIC SYNTHESIS AND INDUSTRIAL ORGANIC CHEMISTRY Synthesis of 2-Chloromethyl-5-aryl-, 2-Chloromethyl- 5-(5-methyl-2-furyl)-, and 2-Chloromethyl-5-(1,5-dimethyl- 2-pyrrolyl)-1,3,4-oxadiazoles from Tetrazole Derivatives , 2005 .

[137]  A. Zarghi,et al.  Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles. , 2005, Bioorganic & medicinal chemistry letters.

[138]  N. Oikonomakos,et al.  Kinetic and crystallographic studies on 2‐(β‐D‐glucopyranosyl)‐5‐methyl‐1, 3, 4‐oxadiazole, ‐benzothiazole, and ‐benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site , 2005, Protein science : a publication of the Protein Society.

[139]  D. Boger,et al.  Discovery of an exceptionally potent and selective class of fatty acid amide hydrolase inhibitors enlisting proteome-wide selectivity screening: concurrent optimization of enzyme inhibitor potency and selectivity. , 2005, Bioorganic & medicinal chemistry letters.

[140]  A. Çetin,et al.  5-Furan-2yl[1,3,4]oxadiazole-2-thiol, 5-Furan-2yl-4H [1,2,4] triazole-3-thiol and Their Thiol-Thione Tautomerism , 2005, Molecules.

[141]  A. Shafiee,et al.  Synthesis and anticonvulsant activity of new 2-substituted-5- [2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles. , 2004, Bioorganic & medicinal chemistry letters.

[142]  David A. Lustig,et al.  CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability. , 2004, Bioorganic & medicinal chemistry letters.

[143]  A. Shafiee,et al.  Radiosynthesis of [18F]-5-[2-(2-chlorophenoxy)phenyl]-1,3,4-oxadiazole-2-yl-4-fluorobenzoate: A labeled ligand for benzodiazepine receptors , 2004 .

[144]  Romualdas Smicius,et al.  Synthesis and anti-inflammatory activity of derivatives of 5-[(2-disubstitutedamino-6-methyl-pyrimidin-4-yl)-sulfanylmethyl]-3H-1,3,4-oxadiazole-2-thiones. , 2004, Farmaco.

[145]  J. Lehmann,et al.  Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(1-adamantyl)-2-substituted thio-1,3,4-oxadiazoles and 5-(1-adamantyl)-3-substituted aminomethyl-1,3,4-oxadiazoline-2-thiones. , 2004, Bioorganic & medicinal chemistry.

[146]  W. Schleif,et al.  P1' oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1. , 2004, Bioorganic & medicinal chemistry letters.

[147]  K. Shikha,et al.  Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of some new 2-[(2,6-dichloroanilino) phenyl]acetic acid derivatives. , 2004, European journal of medicinal chemistry.

[148]  B. G. Rao,et al.  Inhibitors of hepatitis C virus NS3.4A protease 2. Warhead SAR and optimization. , 2004, Bioorganic & medicinal chemistry letters.

[149]  Martin Poirier,et al.  Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061. , 2004, Journal of medicinal chemistry.

[150]  G. Sharma,et al.  Zirconium(IV) Chloride Mediated Cyclodehydration of 1,2‐Diacylhydrazines: A Convenient Synthesis of 2,5‐Diaryl 1,3,4‐Oxadiazoles , 2004 .

[151]  Paul Bamborough,et al.  Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3/P4 urea leads to potent intracellular inhibitors of hepatitis C virus NS3/4A protease. , 2003, Organic letters.

[152]  Z. Bian,et al.  High-performance blue electroluminescent devices based on 2-(4-biphenylyl)-5-(4-carbazole-9-yl)phenyl-1,3,4-oxadiazole. , 2003, Chemical communications.

[153]  Yanli Wang,et al.  Syntheses and insecticidal activities of novel 2,5-disubstituted 1,3,4-oxadiazoles , 2003 .

[154]  S. Mashraqui,et al.  An Expeditious and Convenient One Pot Synthesis of 2,5-Disubstituted-1,3,4-oxadiazoles , 2003 .

[155]  Zhisheng Jiang,et al.  Synthesis and antifeedant activity of new oxadiazolyl 3(2H)-pyridazinones. , 2003, Journal of agricultural and food chemistry.

[156]  M. Goldman,et al.  Structure–Activity Relationship Studies of Ethyl 2-[(3-Methyl-2,5-dioxo(3-pyrrolinyl))amino]-4-(trifluoromethyl)pyrimidine-5-carboxylate: An Inhibitor of AP-1 and NF-κB Mediated Gene Expression , 2002 .

[157]  N. Thornberry,et al.  Discovery of potent, selective human granzyme B inhibitors that inhibit CTL mediated apoptosis. , 2002, Bioorganic & medicinal chemistry letters.

[158]  A. Katritzky,et al.  Syntheses of 5-(2-arylazenyl)-1,2,4-triazoles and 2-amino-5-aryl-1,3,4-oxadiazoles , 2002 .

[159]  M. Ozalp,et al.  Synthesis and antimicrobial activity of some 1,3,4-oxadiazole derivatives. , 2002, Farmaco.

[160]  A. Maslat,et al.  Synthesis, antibacterial, antifungal and genotoxic activity of bis-1,3,4-oxadiazole derivatives. , 2002, Polish journal of pharmacology.

[161]  Guangxing Yang,et al.  Syntheses and biological activities of novel diheterocyclic compounds containing 1,2,4‐triazolo[1,5‐a]pyrimidine and 1,3,4‐oxadiazole , 2001 .

[162]  L. W. Spruce,et al.  Development of orally active nonpeptidic inhibitors of human neutrophil elastase. , 2001, Journal of medicinal chemistry.

[163]  L. W. Spruce,et al.  Design and synthesis of new orally active nonpeptidic inhibitors of human neutrophil elastase. , 2000, Journal of medicinal chemistry.

[164]  Rong Zhang,et al.  Syntheses and insecticidal activities of novel 2-fluorophenyl-5-aryl/cyclopropyl-1,3,4-oxadiazoles , 2000 .

[165]  Y. Matsumoto,et al.  Studies on anti-Helicobacter pylori agents. Part 2: new cephem derivatives. , 2000, Bioorganic & medicinal chemistry.

[166]  Mark E. Thompson,et al.  Statistical Copolymers with Side-Chain Hole and Electron Transport Groups for Single-Layer Electroluminescent Device Applications , 2000 .

[167]  H. Wikström,et al.  New selective and potent 5-HT(1B/1D) antagonists: chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides. , 2000, Journal of medicinal chemistry.

[168]  C. J. Blankley,et al.  Heterocyclic ureas: inhibitors of acyl-CoA:cholesterol O-acyltransferase as hypocholesterolemic agents. , 1996, Journal of medicinal chemistry.